LALPATHLAB
Invest with MTF
Invest Now
Invest in Dr. Lal Pathlabs with 3.53X leverage
Performance
- Low
- ₹2,862
- High
- ₹2,924
- 52 Week Low
- ₹2,294
- 52 Week High
- ₹3,540
- Open Price₹2,903
- Previous Close₹2,885
- Volume75,502
Investment Returns
- Over 1 Month -6.53%
- Over 3 Month -12.78%
- Over 6 Month -4.05%
- Over 1 Year -9.18%
Smart Investing Starts Here Start SIP with Dr. Lal Pathlabs for Steady Growth!
Dr. Lal Pathlabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 44.9
- PEG Ratio
- 1.4
- Market Cap Cr
- 23,994
- P/B Ratio
- Average True Range
- 81.72
- EPS
- 63.78
- Dividend Yield
- 0.9
- MACD Signal
- -37.48
- RSI
- 32.24
- MFI
- 11.96
Dr. Lal Pathlabs Financials
Dr. Lal Pathlabs Technicals
EMA & SMA
Current Price
₹2,864.10
-21.2
(-0.73%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹3,029.40
- 50 Day
- ₹3,091.27
- 100 Day
- ₹3,090.09
- 200 Day
- ₹3,028.98
Resistance and Support
2872.43
- R3 2,952.37
- R2 2,921.43
- R1 2,903.37
- S1 2,854.37
- S2 2,823.43
- S3 2,805.37
Dr. Lal Pathlabs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-10-31 | Qtr Results, Int.Dividend & Bonus issue | |
| 2025-07-31 | Quarterly Results, Dividend & Others | To consider other business matters. per share (60%) Second Interim Dividend |
| 2025-04-25 | Audited Results & Final Dividend | |
| 2025-01-30 | Quarterly Results, Dividend & Others | To consider other business matters. per share (60%) Second Interim Dividend |
| 2024-10-23 | Quarterly Results & Interim Dividend |
Dr. Lal Pathlabs F&O
About Dr. Lal Pathlabs
- NSE Symbol
- LALPATHLAB
- BSE Symbol
- 539524
- ISIN
- INE600L01024
Similar Stocks to Dr. Lal Pathlabs
Dr. Lal Pathlabs FAQs
Dr. Lal Pathlabs share price is ₹2,864 As on 12 December, 2025 | 12:14
The Market Cap of Dr. Lal Pathlabs is ₹23994.1 Cr As on 12 December, 2025 | 12:14
The P/E ratio of Dr. Lal Pathlabs is 44.9 As on 12 December, 2025 | 12:14
The PB ratio of Dr. Lal Pathlabs is 11 As on 12 December, 2025 | 12:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.